SCHEMBL14722714

SCHEMBL14722714

Cc1nn(C)c(C)c1-c1ccc(C=C2CCN(C3CCC3)CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 8/20 0.41
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
BRD4 O60885 1/20 0.35
CREBBP Q92793 1/20 0.35
HPGD P15428 3/20 0.33
MAP4K1 Q92918 1/20 0.33
HTR7 P34969 3/20 0.33
HTR1A P08908 2/20 0.33
CHRM5 P08912 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
HTR3A P46098 1/20 0.33
HTR5A P47898 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
NMT1 P30419 1/20 0.32
PROKR1 Q8TCW9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14722166 0.80 CYP11B2 (0.42) HRH3HSD17B10BRD4CREBBPHPGD
SCHEMBL14721566 0.80 BRD4 (0.52) HRH3BRD4
SCHEMBL14721988 0.76 KDM2B (0.51) HRH3BRD4CREBBPKDM2B
SCHEMBL14722014 0.75 HRH3 (0.41) HRH3BRD4CREBBP
SCHEMBL14721971 0.74 HRH3 (0.39) HRH3PROKR1KDM2B
SCHEMBL14722914 0.73 MAOA (0.39) HRH3
SCHEMBL14722041 0.73 HRH3 (0.52) HRH3
SCHEMBL14722994 0.73 GRM5 (0.42) BRD4CREBBP
SCHEMBL14730970 0.72 ACHE (0.42) HRH3
SCHEMBL7886548 0.72 MAPT (0.41) HRH3MAPK1HSD17B10HPGDMAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed